TheraSphere
Total Payments
$1.1M
Transactions
142
Doctors
41
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $1.1M | 142 | 41 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $986,258 | 54 | 90.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $58,625 | 41 | 5.4% |
| Consulting Fee | $37,349 | 44 | 3.4% |
| Honoraria | $4,200 | 1 | 0.4% |
| Food and Beverage | $22.90 | 1 | 0.0% |
| Travel and Lodging | $22.68 | 1 | 0.0% |
Payments by Type
Research
$986,258
54 transactions
General
$100,220
88 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| EPOCH TS-102 | BOSTON SCIENTIFIC CORPORATION | $437,591 | 0 |
| TS-103 STOP-HCC | BOSTON SCIENTIFIC CORPORATION | $323,936 | 0 |
| Y90 Radioembolization for Hepatocellular Carcinoma Patients with Personalized Dosimetry for Curative Intent | BOSTON SCIENTIFIC CORPORATION | $74,425 | 0 |
| Immunotherapy combined with Yttrium-90 RadioEmbolization in the treatment Colorectal Cancer with Liver Metastases [iRE-C Clinical Trial] | Boston Scientific Corporation | $62,564 | 0 |
| Y90 Radioembolization for HCC Patients w/Personalized Dosimetry for Curative Intent | BOSTON SCIENTIFIC CORPORATION | $46,569 | 0 |
| Immune Biomarker Analysis on GI15-225 Pilot Study of Pembrolizumab in Combination w/Y90 Radioembolization in Subjects w/Poor Prognosis HCC w/Preserved Liver Function | BOSTON SCIENTIFIC CORPORATION | $20,643 | 0 |
| Tc99m_MAA Bronchial Artery Injection During Bronchial Embolization | BOSTON SCIENTIFIC CORPORATION | $14,692 | 0 |
| STOP-HCC TS-103 | BOSTON SCIENTIFIC CORPORATION | $2,761 | 0 |
| TARGET study | BOSTON SCIENTIFIC CORPORATION | $2,454 | 0 |
| EPOCH | BOSTON SCIENTIFIC CORPORATION | $625.00 | 0 |
Top Doctors Receiving Payments for TheraSphere — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Diagnostic Radiology | New York, NY | $1,200 | 1 |
| , M.D | Vascular & Interventional Radiology | Huntsville, AL | $900.00 | 1 |
| , MD | Vascular & Interventional Radiology | Federal Way, WA | $900.00 | 1 |
| , MD | Nuclear Medicine | Bronx, NY | $840.00 | 2 |
| , MD | Diagnostic Radiology | Indianapolis, IN | $750.00 | 2 |
| , MD | Student in an Organized Health Care Education/Training Program | Chicago, IL | $750.00 | 1 |
| , MD | Vascular & Interventional Radiology | Jacksonville, FL | $750.00 | 1 |
| , M.D | Diagnostic Radiology | New York, NY | $675.00 | 1 |
| , M.D | Diagnostic Radiology | Sacramento, CA | $675.00 | 1 |
| , M.D | Vascular & Interventional Radiology | Boston, MA | $500.00 | 1 |
| , MD | Vascular & Interventional Radiology | Chicago, IL | $500.00 | 1 |
| , MD | Transplant Surgery | Salt Lake City, UT | $450.00 | 1 |
| , MD | Internal Medicine | Philadelphia, PA | $375.00 | 1 |
| , M.D | Nuclear Imaging & Therapy | Tampa, FL | $375.00 | 1 |
| , MD | Diagnostic Radiology | Indianapolis, IN | $375.00 | 1 |
| Guy Johnson | Diagnostic Radiology | Seattle, WA | $375.00 | 1 |
| , M.D | Internal Medicine | Boston, MA | $337.50 | 1 |
Ad
Manufacturing Companies
- BOSTON SCIENTIFIC CORPORATION $927,895
- Boston Scientific Corporation $158,583
Product Information
- Type Device
- Total Payments $1.1M
- Total Doctors 41
- Transactions 142
About TheraSphere
TheraSphere is a device associated with $1.1M in payments to 41 healthcare providers, recorded across 142 transactions in the CMS Open Payments database. The primary manufacturer is BOSTON SCIENTIFIC CORPORATION.
Payment data is available from 2021 to 2021. In 2021, $1.1M was paid across 142 transactions to 41 doctors.
The most common payment nature for TheraSphere is "Unspecified" ($986,258, 90.8% of total).
TheraSphere is associated with 10 research studies, including "EPOCH TS-102" ($437,591).